ArticleDiscover oncology2022

Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapy.

Miaomiao Gou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.